Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19).
Catherine DeVoeMark R SegalLusha WangKim StanleySharline MaderaJoe FanJonathan SchouestRenee Graham-OjoAmy NicholsPriya A PrasadRajani GhaleChristina LoveYumiko Abe-JonesKirsten N KangelarisSarah L PattersonDeborah S YokoeCharles R LangelierPublished in: Infection control and hospital epidemiology (2021)
COVID-19 is associated with an increased risk of IVAC, PVAP, and Enterococcus BSI compared with hospitalized controls, which is not fully explained by factors such as immunosuppressive treatments and duration of mechanical ventilation. The mechanism underlying increased rates of Enterococcus BSI in COVID-19 patients requires further investigation.
Keyphrases
- coronavirus disease
- mechanical ventilation
- sars cov
- end stage renal disease
- respiratory syndrome coronavirus
- biofilm formation
- acute respiratory distress syndrome
- ejection fraction
- intensive care unit
- chronic kidney disease
- newly diagnosed
- respiratory failure
- escherichia coli
- pseudomonas aeruginosa
- cystic fibrosis